FDA Changes Approach to Homeopathic Products, Sharpless Says

In a joint statement, acting FDA Commissioner Ned Sharpless and CDER Director Janet Woodcock announced that the agency is changing its approach to regulating homeopathic drug products that pose significant risks to patients.
Source: Drug Industry Daily